Adrenal cortex tissue homeostasis and zonation: A WNT perspective

Molecular and Cellular Endocrinology

Volumn 408, Issue , 2014, Pages 156-164

  Drelon, Coralie ^a   Berthon, Annabel ^a,b   Mathieu, Mickael ^a   Martinez, Antoine ^a   Val, Pierre ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

ACTH PKA; Adrenal cortex; Differentiation; Hedgehog; WNT catenin; Zonation

Indexed keywords

WNT PROTEIN;

ADRENAL CORTEX; ANIMAL; BIOLOGICAL MODEL; CELL SELF-RENEWAL; CYTOLOGY; HOMEOSTASIS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

ADRENAL CORTEX; ANIMALS; CELL SELF RENEWAL; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84926655538     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.12.014     Document Type: Review

References (81)

1. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997, 16:3797-3804.
2. Almeida M.Q., Azevedo M.F., Xekouki P., Bimpaki E.I., Horvath A., Collins M.T., et al. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations. J. Clin. Endocrinol. Metab 2012, 97:E687-E693.
3. Assié G., Letouzé E., Fassnacht M., Jouinot A., Luscap W., Barreau O., et al. Integrated genomic characterization of adrenocortical carcinoma. Nat. Genet 2014.
4. Benhamouche S., Decaens T., Godard C., Chambrey R., Rickman D.S., Moinard C., et al. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev. Cell 2006, 10:759-770.
5. Bernichtein S., Petretto E., Jamieson S., Goel A., Aitman T.J., Mangion J.M., et al. Adrenal gland tumorigenesis after gonadectomy in mice is a complex genetic trait driven by epistatic loci. Endocrinology 2008, 149:651-661.
6. Berthon A., Sahut-Barnola I., Lambert-Langlais S., de Joussineau C., Damon-Soubeyrand C., Louiset E., et al. Constitutive {beta}-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum. Mol. Genet 2010, 19:1561-1576.
7. Berthon A., Drelon C., Ragazzon B., Boulkroun S., Tissier F., Amar L., et al. WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. Hum. Mol. Genet 2014, 23:889-905.
8. Bovolenta P., Esteve P., Ruiz J.M., Cisneros E., Lopez-Rios J. Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J. Cell Sci 2008, 121:737-746.
9. Chassot A.-A., Gillot I., Chaboissier M.-C. R-spondin1, WNT4 and the CTNNB1 signaling pathway: tight control over ovarian differentiation. Reprod. Camb. Engl 2014.
10. Chassot A.A., Ranc F., Gregoire E.P., Roepers-Gajadien H.L., Taketo M.M., Camerino G., et al. Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary. Hum. Mol. Genet 2008, 17:1264-1277.
11. Chen M., Hornsby P.J. Adenovirus-delivered DKK3/WNT4 and steroidogenesis in primary cultures of adrenocortical cells. Horm. Metab. Res 2006, 38:549-555.
12. Chida D., Nakagawa S., Nagai S., Sagara H., Katsumata H., Imaki T., et al. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:18205-18210.
13. Ching S., Vilain E. Targeted disruption of Sonic Hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. Genesis 2009, 47:628-637.
14. Clark A.J., Weber A. Adrenocorticotropin insensitivity syndromes. Endocr. Rev 1998, 19:828-843.
15. Clark A.J., McLoughlin L., Grossman A. Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 1993, 341:461-462.
16. Clevers H., Nusse R. Wnt/β-catenin signaling and disease. Cell 2012, 149:1192-1205.
17. Cohen M., Briscoe J., Blassberg R. Morphogen interpretation: the transcriptional logic of neural tube patterning. Curr. Opin. Genet. Dev 2013, 23:423-428.
18. Daniels D.L., Weis W.I. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol 2005, 12:364-371.
19. Davidson G., Wu W., Shen J., Bilic J., Fenger U., Stannek P., et al. Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 2005, 438:867-872.
20. De Lau W., Barker N., Low T.Y., Koo B.-K., Li V.S.W., Teunissen H., et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 2011, 476:293-297.
21. De Lau W., Peng W.C., Gros P., Clevers H. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength. Genes Dev 2014, 28:305-316.
22. Diez-Roux G., Banfi S., Sultan M., Geffers L., Anand S., Rozado D., et al. A high-resolution anatomical atlas of the transcriptome in the mouse embryo. PLoS Biol 2011, 9.
23. Drelon C., Berthon A., Ragazzon B., Tissier F., Bandiera R., Sahut-Barnola I., et al. Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models. PLoS ONE 2012, 7:e44171.
24. Du S.J., Purcell S.M., Christian J.L., McGrew L.L., Moon R.T. Identification of distinct classes and functional domains of Wnts through expression of wild-type and chimeric proteins in Xenopus embryos. Mol. Cell. Biol 1995, 15:2625-2634.
25. Ehrlund A., Jonsson P., Vedin L.-L., Williams C., Gustafsson J.-Å., Treuter E. Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells. PLoS ONE 2012, 7:e32080.
26. El Wakil A., Bandulik S., Guy N., Bendahhou S., Zennaro M.-C., Niehrs C., et al. Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex. Hum. Mol. Genet 2012, 21:4922-4929.
27. Ennen W.B., Levay-Young B.K., Engeland W.C. Zone-specific cell proliferation during adrenocortical regeneration after enucleation in rats. Am. J. Physiol. Endocrinol. Metab 2005, 289:E883-E891.
28. Espiard S., Ragazzon B., Bertherat J. Protein kinase A alterations in adrenocortical tumors. Horm. Metab. Res. Horm. Stoffwechselforschung Horm. Metab 2014, 10.1055/s-0034-1385908.
29. Fang X., Yu S.X., Lu Y., Bast R.C., Woodgett J.R., Mills G.B. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11960-11965.
30. Freedman B.D., Kempna P.B., Carlone D.L., Shah M.S., Guagliardo N.A., Barrett P.Q., et al. Adrenocortical zonation results from lineage conversion of differentiated zona glomerulosa cells. Dev. Cell 2013, 26:666-673.
31. Gaujoux S., Tissier F., Groussin L., Libe R., Ragazzon B., Launay P., et al. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. J. Clin. Endocrinol. Metab 2008, 93:4135-4140.
32. Gorrigan R.J., Guasti L., King P., Clark A.J., Chan L.F. Localisation of the melanocortin-2-receptor and its accessory proteins in the developing and adult adrenal gland. J. Mol. Endocrinol 2011, 46:227-232.
33. Gummow B.M., Winnay J.N., Hammer G.D. Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene. J. Biol. Chem 2003, 278:26572-26579.
34. Hatano O., Takakusu A., Nomura M., Morohashi K. Identical origin of adrenal cortex and gonad revealed by expression profiles of Ad4BP/SF-1. Genes Cells 1996, 1:663-671.
35. Hattangady N.G., Olala L.O., Bollag W.B., Rainey W.E. Acute and chronic regulation of aldosterone production. Mol. Cell. Endocrinol 2012, 350:151-162.
36. Heikkila M., Peltoketo H., Leppaluoto J., Ilves M., Vuolteenaho O., Vainio S. Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 2002, 143:4358-4365.
37. Heitzmann D., Derand R., Jungbauer S., Bandulik S., Sterner C., Schweda F., et al. Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO J. 2008, 27:179-187.
38. Hino S., Tanji C., Nakayama K.I., Kikuchi A. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination. Mol. Cell. Biol 2005, 25:9063-9072.
39. Holmen S.L., Salic A., Zylstra C.R., Kirschner M.W., Williams B.O. A novel set of Wnt-Frizzled fusion proteins identifies receptor components that activate beta-catenin-dependent signaling. J. Biol. Chem 2002, 277:34727-34735.
40. Huang C.C., Miyagawa S., Matsumaru D., Parker K.L., Yao H.H. Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog. Endocrinology 2010, 151:1119-1128.
41. Kang D.E., Soriano S., Xia X., Eberhart C.G., De Strooper B., Zheng H., et al. Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell 2002, 110:751-762.
42. Kim A.C., Reuter A.L., Zubair M., Else T., Serecky K., Bingham N.C., et al. Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex. Development 2008, 135:2593-2602.
43. King P., Paul A., Laufer E. Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21185-21190.
44. King P.J., Guasti L., Laufer E. Hedgehog signalling in endocrine development and disease. J. Endocrinol 2008, 198:439-450.
45. Kirschner L.S. A unified cause for adrenal Cushing's syndrome. Science 2014, 344:804-805.
46. Koo B.-K., Spit M., Jordens I., Low T.Y., Stange D.E., van de Wetering M., et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 2012, 488:665-669.
47. Laufer E., Kesper D., Vortkamp A., King P. Sonic hedgehog signaling during adrenal development. Mol. Cell. Endocrinol 2012, 351:19-27.
48. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.
49. Mandel H., Shemer R., Borochowitz Z.U., Okopnik M., Knopf C., Indelman M., et al. SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. Am. J. Hum. Genet 2008, 82:39-47.
50. Mao B., Wu W., Davidson G., Marhold J., Li M., Mechler B.M., et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 2002, 417:664-667.
51. McGlinn E., Tabin C.J. Mechanistic insight into how Shh patterns the vertebrate limb. Curr. Opin. Genet. Dev 2006, 16:426-432.
52. Meimaridou E., Hughes C.R., Kowalczyk J., Guasti L., Chapple J.P., King P.J., et al. Familial glucocorticoid deficiency: new genes and mechanisms. Mol. Cell. Endocrinol 2013, 371:195-200.
53. Metherell L.A., Chapple J.P., Cooray S., David A., Becker C., Rüschendorf F., et al. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat. Genet 2005, 37:166-170.
54. Mikels A.J., Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 2006, 4:e115.
55. Miller J.R. The Wnts. Genome Biol 2002, 3. REVIEWS3001.
56. Mitani F. Functional zonation of the rat adrenal cortex: the development and maintenance. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci 2014, 90:163-183.
57. Mitani F., Miyamoto H., Mukai K., Ishimura Y. Effects of long term stimulation of ACTH and angiotensin II-secretions on the rat adrenal cortex. Endocr. Res 1996, 22:421-431.
58. Mitani F., Mukai K., Ogawa T., Miyamoto H., Ishimura Y. Expression of cytochromes P450aldo and P45011 beta in rat adrenal gland during late gestational and neonatal stages. Steroids 1997, 62:57-61.
59. Mitani F., Mukai K., Miyamoto H., Suematsu M., Ishimura Y. Development of functional zonation in the rat adrenal cortex. Endocrinology 1999, 140:3342-3353.
60. Mosimann C., Hausmann G., Basler K. Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat. Rev. Mol. Cell Biol 2009, 10:276-286.
61. Nakamura R.E., Hackam A.S. Analysis of Dickkopf3 interactions with Wnt signaling receptors. Growth Factors 2010, 28:232-242.
62. Nakamura R.E., Hunter D.D., Yi H., Brunken W.J., Hackam A.S. Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina. BMC Cell Biol 2007, 8:52.
63. Novoselova T.V., Jackson D., Campbell D.C., Clark A.J.L., Chan L.F. Melanocortin receptor accessory proteins in adrenal gland physiology and beyond. J. Endocrinol 2013, 217:R1-R11.
64. Ragazzon B., Lefrancois Martinez A.M., Val P., Sahut-Barnola I., Tournaire C., Chambon C., et al. ACTH-dependent changes in SF-1/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis. Endocrinology 2006, 147:1805-1818.
65. Sahut-Barnola I., de Joussineau C., Val P., Lambert-Langlais S., Damon C., Lefrancois Martinez A.M., et al. Cushing's syndrome and foetal features resurgence in adrenal cortex-specific Prkar1a knockout mice. PLoS Genet 2010, 6:e1000980.
66. Salmon T., Zwemer R. A study of the life history of cortico-adrenal gland cells of the rat by means of trypan blue injections. Anat. Rec 1941, 80:421-429.
67. Schimmer B.P., White P.C. Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. Mol. Endocrinol. Baltim. MD 2010, 24:1322-1337.
68. Semënov M.V., Tamai K., Brott B.K., Kühl M., Sokol S., He X. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr. Biol. CB 2001, 11:951-961.
69. Suwa T., Chen M., Hawks C.L., Hornsby P.J. Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex. J. Endocrinol 2003, 178:149-158.
70. Tadjine M., Lampron A., Ouadi L., Horvath A., Stratakis C.A., Bourdeau I. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease. Clin. Endocrinol. (Oxf) 2008, 69:367-373.
71. Taurin S., Sandbo N., Qin Y., Browning D., Dulin N.O. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J. Biol. Chem 2006, 281:9971-9976.
72. Ulrich-Lai Y.M., Figueiredo H.F., Ostrander M.M., Choi D.C., Engeland W.C., Herman J.P. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am. J. Physiol. Endocrinol. Metab 2006, 291:E965-E973.
73. Val P., Swain A. Gene dosage effects and transcriptional regulation of early mammalian adrenal cortex development. Mol. Cell. Endocrinol 2010, 323:105-114.
74. Val P., Lefrancois Martinez A.M., Veyssiere G., Martinez A. SF-1 a key player in the development and differentiation of steroidogenic tissues. Nucl. Recept 2003, 1.
75. Visel A., Thaller C., Eichele G. GenePaint.org: an atlas of gene expression patterns in the mouse embryo. Nucleic Acids Res 2004, 32:D552-D556.
76. Walczak E.M., Hammer G.D. Regulation of the adrenocortical stem cell niche: implications for disease. Nat. Rev. Endocrinol 2014.
77. Walczak E.M., Kuick R., Finco I., Bohin N., Hrycaj S.M., Wellik D.M., et al. Wnt-signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms. Mol. Endocrinol. Baltim. Md 2014, me20141060.
78. Wotus C., Levay-Young B.K., Rogers L.M., Gomez-Sanchez C.E., Engeland W.C. Development of adrenal zonation in fetal rats defined by expression of aldosterone synthase and 11b-hydroxylase. Endocrinology 1998, 139:4397-4403.
79. Yates R., Katugampola H., Cavlan D., Cogger K., Meimaridou E., Hughes C., et al. Adrenocortical development, maintenance, and disease. Curr. Top. Dev. Biol 2013, 106:239-312.
80. Ye P., Nakamura Y., Lalli E., Rainey W.E. Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology 2009, 150:1303-1309.
81. Zeng X., Tamai K., Doble B., Li S., Huang H., Habas R., et al. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 2005, 438:873-877.